SAN MATEO, Calif., Dec. 16, 2020 /PRNewswire/ — Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, announced today the closing of a $30 million Series C fin… […]
SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ — Singlera Genomics Inc. today announced that it raised $150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Cap… […]
LA JOLLA, Calif., Dec. 8, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced the closing of its previous… […]
SAN DIEGO, Nov. 19, 2020 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the Company has entered into separate, privately negotiated transactions (the “Agreements”) with certain holders of its existing 2.25% Convert… […]
SAN DIEGO, Oct. 15, 2020 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) announced today that it has sold $25 million of unsecured convertible promissory notes to funds affiliated with Adjuvant Capital, LP (“Adjuvant Capital”). The notes a… […]
Genelux closes on first tranche of a convertible debt and warrant financing of up to $20M to fund the continued clinical development of Olvi-Vec, its lead oncolytic immunotherapy candidate
SAN DIEGO, Sept. 25, 2020 /PRNewswire/ — Genelux Corporation… […]
LA JOLLA, Calif., Aug. 31, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that pursuant to an amendm… […]
First early cancer-detection company to use microbial biomarkers in diagnostics
SAN DIEGO, Aug. 13, 2020 /PRNewswire/ — Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based metho… […]
The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines
SINGAPORE and SAN DIEGO, Aug. 12, 2020 /PRNewswire/ — ImmunoSc… […]
CAMBRIDGE, England and BRISTOL, Pa. and SAN DIEGO, July 28, 2020 /PRNewswire/ — Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADC… […]
Copyright © 2021 Biotech Networks, LLC
